The Galien Foundation

The Galien Foundation is delighted to announce the 2024 #PrixGalien USA Award nominees for “Best Biotechnology Product," "Best Pharmaceutical Product", and "Best Product for Rare/Orphan Diseases", ahead of the prestigious #PrixGalien Awards Ceremony at the American Museum of Natural History, in New York. For the full list of nominees, please visit: https://galien.org/3ytYhgP

Amgen’s Impact Amgen, a leader in biotechnology, has received 25 Prix Galien medals since 1970 for its breakthroughs in medical research. Their pioneering work in biologics, including treatments for cancer and cardiovascular diseases, exemplifies Amgen's commitment to advancing science and transforming patient lives. These innovations are crucial in providing effective therapies for complex conditions. The Prix Galien Awards recognize these achievements, highlighting the critical role of biotech in modern medicine. #Amgen #Biotechnology #MedicalResearch #PrixGalien

Join us at the Galien Forum USA 2024 for an enlightening panel on Big Biotech! 🌟 We're honored to welcome an esteemed group of experts who are shaping the future of biotechnology: 🔬 Phillip Sharp - 1993 Nobel Laureate for Physiology or Medicine, Institute Professor and Biology Emeritus at MIT's MIT MIT Koch Institute for Integrative Cancer Research, and Co-Chair of the Galien Forum (Panel Chair). 🔬 Jay Bradner - Executive Vice President, Research & Development and Chief Scientific Officer, Amgen (Panelist). 🔬 Pushkal Garg - Chief Medical Officer and Executive Vice President, Development & Medical Affairs, Alnylam Pharmaceuticals (Panelist). 🔬 Jane Grogan - Executive Vice President and Head of Research, Biogen (Panelist). 🔬 george yancopoulos - Board Co-Chair, President & Chief Scientific Officer, Regeneron Pharmaceuticals (Panelist). Dive into groundbreaking discussions, innovative ideas, and future-forward insights with leaders at the forefront of biotech research and development. 👉 Watch out for the newsletter coming out soon for more details! #GalienForum #BigBiotech #Innovation #Biotechnology #Healthcare #ResearchAndDevelopment #BiotechLeaders #FutureOfHealth #MedicalInnovation

In June, we honored our award winners at the International #PrixGalien in Rome. Hear now from Novartis, the winner in the Best Biotechnology Product category: https://lnkd.in/e-w4swDD

Sanofi’s Impact Sanofi has earned 39 Prix Galien medals since 1970 for its significant contributions to healthcare. Noteworthy products like Dupixent® for dermatology and Eloxatin® for oncology demonstrate Sanofi's dedication to advancing medical treatments and improving patient care worldwide. These accomplishments highlight Sanofi's role in addressing diverse medical needs and enhancing quality of life through innovative therapies. The Prix Galien Awards honor these milestones, underscoring the importance of pioneering pharmaceutical research. #Sanofi #Pharmaceuticals #Innovation #PrixGalien

Janssen Pharmaceuticals’ Impact Since 1970, The Janssen Pharmaceutical Companies of Johnson & Johnson Pharmaceuticals, a part of Johnson & Johnson has won 40 Prix Galien medals for its contributions to medical science. Their advancements in treating multi-drug resistant tuberculosis (MDR-TB) and hepatitis C with medications like Bedaquiline and Telaprevir highlight their commitment to tackling critical public health issues. These innovations are vital in improving patient outcomes and combating global diseases. The Prix Galien Awards celebrate these achievements, emphasizing the importance of continued pharmaceutical research and development. #Janssen #Pharmaceuticals #GlobalHealth #PrixGalien

GSK’s Impact GSK has garnered, since 1970, 41 Prix Galien medals for its notable contributions to vaccines and pharmaceuticals. Their Shingrix® vaccine protects against shingles, while Engerix-B prevents hepatitis B, reflecting GSK's dedication to preventive healthcare. These innovations are pivotal in reducing the global disease burden and improving health outcomes. The Prix Galien Awards celebrate these groundbreaking contributions, underscoring the significance of preventative healthcare. #GSK #Vaccines #PreventiveHealthcare #Shingrix #PrixGalien

Pfizer’s Excellence in Pharmaceuticals Pfizer, with 43 Prix Galien medals, since 1970, has achieved remarkable milestones in various therapeutic areas. Their Pfizer- Prevnar® vaccine has drastically reduced pneumonia cases in children, while Comirnaty®, the well-known COVID-19 vaccine, highlights Pfizer's commitment to fighting infectious diseases and protecting public health. Pfizer continues to lead with its innovative solutions. The Prix Galien Awards honor such dedication to advancing medical science and improving human health. #Pfizer #Vaccines #COVID19 #PublicHealth #PrixGalien

Roche’s Legacy of Innovation Roche, boasting 56 Prix Galien medals, since 1970, continues to pioneer advancements in medical technology and oncology. Their groundbreaking drug Herceptin® has revolutionized breast cancer treatment by targeting the HER2 protein, significantly improving survival rates and quality of life for many patients. Roche’s commitment to precision medicine continues to make a profound impact on healthcare. The Prix Galien Awards recognize such excellence, honoring innovations that change the landscape of medical science. #Roche #BreastCancer #MedicalTechnology #PrecisionMedicine #PrixGalien

Honoring Novartis With 77 Prix Galien medals, since 1970, Novartis is a beacon of innovation in oncology and dermatology. Their revolutionary drug Gleevec® has transformed cancer treatment by targeting cancer cells specifically, providing new hope for patients worldwide. Additionally, Cosentyx® has set new standards in dermatology, offering effective relief for chronic skin conditions. Novartis continues to lead with its cutting-edge research and development. The Prix Galien Awards celebrate such transformative advancements, highlighting the impact of Novartis on global health. #Novartis #Oncology #Dermatology #PharmaInnovation #PrixGalien